ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2024, Vol 14, No. 4

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Original Research

1. Protective Effects of Crocus Sativus L. Extract and Crocin against Chronic-Stress Induced Oxidative Damage of Brain, Liver and Kidneys in Rats

Ahmad Reza Bandegi, Ali Rashidy-Pour, Abbas Ali Vafaei*, Behshid Ghadrdoost

Adv Pharm Bull. 2014;4(6): 493-499. doi: 10.5681/apb.2014.073

PMCID: PMC4312396 PMID: 25671180 Scopus ID: 84921960684

Article

PDF

XML

Cited By:

Original Research

2. Ghrelin Improves Antioxidant Defense in Blood and Brain in Normobaric Hypoxia in Adult Male Rats

Hasan Omrani, Mohammad Reza Alipour, Gisou Mohaddes*

Adv Pharm Bull. 2015;5(2): 283-288. doi: 10.15171/apb.2015.039

PMCID: PMC4517091 PMID: 26236669 Scopus ID: 84930390766

Article

PDF

XML

Cited By:

Review Article

3. Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective

Shringika Soni, Rakesh Kumar Ruhela, Bikash Medhi*

Adv Pharm Bull. 2016;6(3): 319-335. doi: 10.15171/apb.2016.044

PMCID: PMC5071795 PMID: 27766216 Scopus ID: 84995578310

Article

PDF

XML

Cited By:

Research Article

4. Effect of Whey Protein Supplementation on Inflammatory and Antioxidant Markers, and Clinical Prognosis in Acute Ischemic Stroke (TNS Trial): A Randomized, Double Blind, Controlled, Clinical Trial

Mazyar Hashemilar , Mohammad Khalili* , Nasim Rezaeimanesh, Elyar Sadeghi Hokmabadi, Sevin Rasulzade, Seyed Morteza Shamshirgaran, Aliakbar Taheraghdam , Mehdi Farhoudi* , Sheyda Shaafi, Seyed Kazem Shakouri , Daryoush Savadi Osgouei

Adv Pharm Bull. 2020;10(1): 135-140. doi: 10.15171/apb.2020.018

PMCID: PMC6983999 PMID: 32002373 Scopus ID: 85084215060

Article

PDF

Full Text

XML

Cited By:

Review Article

5. Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia

Rajalakshmi Rajendran , Krishnakumar Neelakandha Menon*, Sreeja Chandrasekharan Nair*

Adv Pharm Bull. 2022;12(3): 490-508. doi: 10.34172/apb.2022.052

PMCID: PMC9348538 PMID: 35935056 Scopus ID: 85140416915

Article

PDF

Full Text

XML

Cited By:

Research Article

6. Targeting Mitochondrial and Brain Injury Markers in Acquired Brain Injuries: A Randomized, Double-Blind, Placebo-Controlled Study with Melatonin

Bahareh Hakiminia , Babak Alikiaie, Fariborz Khorvash, Sarah Mousavi*

Adv Pharm Bull. 2022;12(1): 118-127. doi: 10.34172/apb.2022.013

PMCID: PMC9012913 PMID: 35517892 Scopus ID: 85127091933

Article

PDF

Full Text

XML

Cited By:

Mini Review

7. Nanostructured Lipid Carriers for Nose to Brain Delivery TargetingCNS: Diversified Role of Liquid Lipids for Synergistic Action

Avinash Ramrao Tekade* , Pradeep Sadanand Mittha, Charushila Sopan Pisal

Adv Pharm Bull. 2022;12(4): 763-771. doi: 10.34172/apb.2022.078

PMCID: PMC9675932 PMID: 36415627 Scopus ID: 85140273140

Article

PDF

Full Text

XML

Cited By:

Review Article

8. Liver X Receptor as a Possible Drug Target for Blood-Brain Barrier Integrity

Mahsa Eskandari , Ali Awsat Mellati*

Adv Pharm Bull. 2022;12(3): 466-475. doi: 10.34172/apb.2022.050

PMCID: PMC9348539 PMID: 35935038 Scopus ID: 85140272061

Article

PDF

Full Text

XML

Cited By:

Mini Review

9. Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors

Soheil Mehrdadi*

Adv Pharm Bull. 2023;13(3): 512-520. doi: 10.34172/apb.2023.062

PMCID: PMC10460802 PMID: 37646057

Article

PDF

Full Text

XML

Cited By:

Mini Review

10. The Role of Estrogen in Brain MicroRNAs Regulation

Peyvand Bahramiazar , Naseh Abdollahzade* , Bakhtyar Tartibian, Naser Ahmadiasl, Fakhreddin Yaghoob Nezhad*

Adv Pharm Bull. 2024;14(4): 819-835. doi: 10.34172/apb.39216

Article

PDF

XML

Cited By:

Research Article

11. Transcending Traditional Treatment: The Therapeutical Potential of Nanovesicles for Transdermal Baclofen Delivery in Repeated Traumatic Brain Injury

Nermin M. Sheta , Amira A. El-Gazar , Ghada M. Ragab , Marwa A. Essa* , Khaled M. Abdel-Haleem , Rania Moataz El-Dahmy

Adv Pharm Bull. 2024;14(2): 346-363. doi: 10.34172/apb.2024.031

PMCID: PMC11347745 PMID: 39206406

Article

PDF

Full Text

XML

Cited By:

Research Article

12. Discovery of a Novel Dual Targeting Peptide for Human Glioma: From In Silico Simulation to Acting as Targeting Ligand

Negar Sedghi Aminabad , Yousef Saeedi, Jamal Adiban, Mahdieh Nemati, Donya Shaterabadi, Farhood Najafi, Reza Rahbarghazi, Mehdi Talebi, Amir Zarebkohan*

Adv Pharm Bull. 2024;14(2): 453-468. doi: 10.34172/apb.2024.033

PMCID: PMC11347739 PMID: 39206396

Article

PDF

Suppl 1

Full Text

XML

Cited By: